The antibiotic polymyxin can pierce the armor of active bacteria, but are ineffective when armor production is shut off in dormant bacteria.

University of Oregon researchers have tested a new combination drug therapy that could dismantle the difficult-to-treat ...

In my work as a veterinary pharmacologist, I never know exactly what I'm going to get when I open my email. It could be a ...

Peta, a flight attendant of 25 years who has travelled the globe for work, has revealed the one item she won't travel without ...

The new study, published in the journal Nature Microbiology, revealed in high-resolution images and biochemical experiments ...

There were no significant differences in outcomes between short- and long-course antibiotic therapy for uncomplicated infections.

Melanie Spero and her lab at the University of Oregon have found that by adding small doses of a simple molecule called chlorate to standard antibiotics, the combination proved 10,000 times more ...

Researchers are calling for an urgent overhaul of diagnostic and treatment guidelines for infections in newborn babies, after ...

University of Oregon researchers have tested a new combination drug therapy that could dismantle the difficult-to-treat bacteria inhabiting chronic wound infections.

CDC reports a major surge in NDM-producing carbapenem-resistant Enterobacterales infections that may defy most antibiotics.

Looking “under the hood” of a cell during chlorate-antibiotic exposure will help investigate how bacteria become susceptible to a range of antibiotics.

Researchers have revealed how polymyxins, crucial last-resort antibiotics, break down bacterial armor by forcing cells to ...